Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Anastasiya Vinokurtseva, Matthew Fung, Erica Ai Li, Richard Zhang, James J Armstrong & Cindy M L Hutnik. (2022) Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis. Clinical Ophthalmology 16, pages 1675-1695.
Read now
Read now
Ying Tang, Caiyun Zhang, Zhigang Zhang & Jinhui Tian. (2019) The efficacy and safety of different long-acting β2-agonists combined with inhaled glucocorticoid regimens in patients with asthma: a network meta-analysis. Journal of Asthma 56:11, pages 1159-1171.
Read now
Read now
Nimit Mehta, Bhumika Aggarwal, Jaideep Gogtay & Sabeer Abdool-Gaffar. (2015) Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma. Expert Opinion on Drug Delivery 12:6, pages 963-975.
Read now
Read now
Teddy Kosoglou, James Hubbell, Fengjuan Xuan, David L Cutler, Alan G Meehan, Bhavna Kantesaria & Bret A Wittmer. (2013) Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 107-116.
Read now
Read now
Christian Grabow Westergaard, Celeste Porsbjerg & Vibeke Backer. (2013) A review of mometasone furoate/formoterol in the treatment of asthma. Expert Opinion on Pharmacotherapy 14:3, pages 339-346.
Read now
Read now
Mario Cazzola, Paola Rogliani, Andrea Segreti & Maria Gabriella Matera. (2012) An update on bronchodilators in Phase I and II clinical trials. Expert Opinion on Investigational Drugs 21:10, pages 1489-1501.
Read now
Read now
Santiago Quirce, Irina Bobolea & Pilar Barranco. (2012) Emerging drugs for asthma. Expert Opinion on Emerging Drugs 17:2, pages 219-237.
Read now
Read now
Dennis E Doherty, Donald P Tashkin, Edward Kerwin, Barbara A Knorr, Tulin Shekar, Sibabrata Banerjee & Heribert Staudinger. (2012) Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 57-71.
Read now
Read now
Donald P Tashkin, Dennis E Doherty, Edward Kerwin, Carlos E Matiz-Bueno, Barbara Knorr, Tulin Shekar, Sibabrata Banerjee & Heribert Staudinger. (2012) Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 43-55.
Read now
Read now
William E Berger. (2011) Mometasone furoate/formoterol in the treatment of persistent asthma. Expert Review of Respiratory Medicine 5:6, pages 739-746.
Read now
Read now
Articles from other publishers (20)
Yuji Oba, Sumayya Anwer, Tarang Patel, Tinashe Maduke & Sofia Dias. (2023) Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2023:8.
Crossref
Crossref
Helen Kathryn Reddel, Guy Brusselle, Rosa Lamarca, Per Gustafson, Gary P. Anderson & Carin Jorup. (2023) Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy. The Journal of Allergy and Clinical Immunology: In Practice 11:7, pages 2104-2114.e3.
Crossref
Crossref
Yuji Oba, Sumayya Anwer, Tinashe Maduke, Tarang Patel & Sofia Dias. (2022) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2022:12.
Crossref
Crossref
Orlagh O'Shea, Elizabeth Stovold & Christopher J Cates. (2021) Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Crossref
Sadia Janjua, Stefanie Schmidt, Montse Ferrer & Christopher J Cates. (2019) Inhaled steroids with and without regular formoterol for asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ziya Salturk, Tolgar Lütfi Kumral, Gürcan Sunnetçi, Yavuz Atar, Çağlar Çakır, Güven Yıldırım, Güler Berkiten & Yavuz Uyar. (2015) Histopathological Analysis of the Effects of Corticosteroids on Vocal Cords: Experimental Study. Indian Journal of Otolaryngology and Head & Neck Surgery 70:1, pages 111-114.
Crossref
Crossref
O M Kurbacheva & K S Pavlova. (2015) Changing the basic treatment as a way to achieve asthma control. Russian Journal of Allergy 12:2, pages 68-74.
Crossref
Crossref
Arzu Tuzuner, Sule Demirci, Gulden Bilgin, Ali Cagli, Filiz Aydogan, Kursat Murat Ozcan & Etem Erdal Samim. (2015) Voice Assessment After Treatment of Subacute and Chronic Cough With Inhaled Steroids. Journal of Voice 29:4, pages 484-489.
Crossref
Crossref
Jorge Maspero, Ivan Cherrez, Dennis E. Doherty, Donald P. Tashkin, Piotr Kuna, Wen-Ling Kuo, Davis Gates, Hendrik Nolte & Leo T. ChylackJr.Jr.. (2014) Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma. Respiratory Medicine 108:9, pages 1355-1362.
Crossref
Crossref
William E. Berger, George W. Bensch, Steven F. Weinstein, David P. Skoner, Bruce M. Prenner, Tulin Shekar, Hendrik Nolte & Ariel A. Teper. (2014) Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma. Pediatric Pulmonology 49:5, pages 441-450.
Crossref
Crossref
KATSUNORI KAGOHASHI, HIROAKI SATOH, GEN OHARA, KUNIHIKO MIYAZAKI, MIO KAWAGUCHI, KOICHI KURISHIMA & NOBUYUKI HIZAWA. (2014) Long-term safety of budesonide/formoterol for the treatment of elderly patients with bronchial asthma. Experimental and Therapeutic Medicine 7:4, pages 1005-1009.
Crossref
Crossref
Santiago Quirce, Irina Bobolea & Pilar Barranco. (2014) Asma: actualización terapéutica. Medicina Clínica 142:7, pages 317-322.
Crossref
Crossref
A V Emelyanov. (2013) New fixed dose combination in treatment of asthma: focus on mometasone furoate/formoterol. Russian Journal of Allergy 10:4, pages 60-64.
Crossref
Crossref
Christopher J Cates, Roman Jaeschke, Stefanie Schmidt & Montse Ferrer. (2013) Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Mario Cazzola, Clive P. Page, Luigino Calzetta & M. Gabriella Matera. (2012) Pharmacology and Therapeutics of Bronchodilators. Pharmacological Reviews 64:3, pages 450-504.
Crossref
Crossref
James E. Frampton. (2012) Mometasone/Formoterol Inhalation Aerosol. Drugs 72:9, pages 1229-1241.
Crossref
Crossref
Toby J Lasserson, Giovanni Ferrara & Lucio Casali. (2011) Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
David I Bernstein, Jacques Hébert, Amarjit Cheema, Kevin R Murphy, Ivan Chérrez-Ojeda, Carlos Eduardo Matiz-Bueno, Wen-Ling Kuo & Hendrik Nolte. (2011) Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma. Allergy, Asthma & Clinical Immunology 7:1.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta & Maria Gabriella Matera. (2011)
β
2
‐adrenoceptor agonists: current and future direction
. British Journal of Pharmacology 163:1, pages 4-17.
Crossref
Crossref
Christopher J Cates & Toby J Lasserson. (2010) Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref